| Year |
Citation |
Score |
| 2009 |
Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochemistry International. 54: 84-8. PMID 19114068 DOI: 10.1016/J.Neuint.2008.10.013 |
0.532 |
|
| 2009 |
Ramiro-Puig E, Casadesús G, Lee HG, Zhu X, McShea A, Perry G, Pérez-Cano FJ, Smith MA, Castell M. Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress. European Journal of Nutrition. 48: 54-61. PMID 19043659 DOI: 10.1007/s00394-008-0761-4 |
0.356 |
|
| 2007 |
McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, Funk JO, Shapiro RA, Smith MA. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochimica Et Biophysica Acta. 1772: 467-72. PMID 17095196 DOI: 10.1016/J.Bbadis.2006.09.010 |
0.553 |
|
| 2006 |
McShea A, Marlatt MW, Lee HG, Tarkowsky SM, Smit M, Smith MA. The application of microarray technology to neuropathology: cutting edge tool with clinical diagnostics potential or too much information? Journal of Neuropathology and Experimental Neurology. 65: 1031-9. PMID 17086099 DOI: 10.1097/01.jnen.0000240471.04920.3c |
0.328 |
|
| 2004 |
Zhu X, McShea A, Harris PL, Raina AK, Castellani RJ, Funk JO, Shah S, Atwood C, Bowen R, Bowser R, Morelli L, Perry G, Smith MA. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. Journal of Neuroscience Research. 75: 698-703. PMID 14991845 DOI: 10.1002/Jnr.20028 |
0.545 |
|
| 2000 |
Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, Feng Y, Ferris DK, Smith MA. Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiology of Aging. 21: 837-41. PMID 11124427 DOI: 10.1016/S0197-4580(00)00218-9 |
0.561 |
|
| 2000 |
Gerst JL, Raina AK, Pirim I, McShea A, Harris PL, Siedlak SL, Takeda A, Petersen RB, Smith MA. Altered cell-matrix associated ADAM proteins in Alzheimer disease. Journal of Neuroscience Research. 59: 680-4. PMID 10686596 DOI: 10.1002/(Sici)1097-4547(20000301)59:5<680::Aid-Jnr11>3.0.Co;2-6 |
0.546 |
|
| 1999 |
Raina AK, Monteiro MJ, McShea A, Smith MA. The role of cell cycle-mediated events in Alzheimer's disease. International Journal of Experimental Pathology. 80: 71-6. PMID 10469261 DOI: 10.1046/J.1365-2613.1999.00106.X |
0.551 |
|
| 1999 |
McShea A, Wahl AF, Smith MA. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Medical Hypotheses. 52: 525-7. PMID 10459833 DOI: 10.1054/mehy.1997.0680 |
0.572 |
|
| 1999 |
McShea A, Zelasko DA, Gerst JL, Smith MA. Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Research. 815: 237-42. PMID 9878757 DOI: 10.1016/S0006-8993(98)01135-4 |
0.507 |
|
| 1997 |
McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. The American Journal of Pathology. 150: 1933-9. PMID 9176387 |
0.517 |
|
| 1997 |
McShea A, R PL, Webster HK, Wahl A, Smith MA. ALTERATIONS OF CDK4 AND P16, CONTROL ELEMENTS OF THE CELL CYCLE, IN ALZHEIMER DISEASE Journal of Neuropathology and Experimental Neurology. 56: 592. DOI: 10.1097/00005072-199705000-00098 |
0.446 |
|
| Show low-probability matches. |
